Abstract

A S L D A b st ra ct s According to common criteria, 11 patients were classified as type 1 HRS, 7 patients had type 2 HRS. After TIPS, HVPG was effectively reduced in all patients (before TIPS: 22,5 mmHg (SD 5,6); after TIPS 5,5 mmHg (SD 3,4)). No major procedure-related complication was observed. Renal function improved within hospital stay (serum creatinine 3.0 mg/dL (SD 2,7) to 1,9 mg/dL (SD 2,8)). Of all patients, 13 (72,2%) could be discharged from hospital with stable or improved renal function, one of them requiring continued hemodialysis; 5 Patients died (27,8%). Of patients with type 1 HRS, 6 (54,5%) were discharged from hospital whereas 5 (45,5%) died. Of patients with type 2 HRS, 6 (86%) survived, 1 patient (0,14%) died during hospital stay. CONCLUSION: In this retrospective study, transjugular intrahepatic portosystemic shunt has been shown to be able to improve renal function in cirrhotic patients with HRS and is associatited with comparatively low in-hospital mortality.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call